Uber Research & Health Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
as on 23-12-2024
- Paid Up Capital ₹ 0.20 M
as on 23-12-2024
- Company Age 10 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.40 Cr
as on 23-12-2024
- Revenue -2.15%
(FY 2023)
- Profit 3.98%
(FY 2023)
- Ebitda -30.08%
(FY 2023)
- Net Worth 22.46%
(FY 2023)
- Total Assets -10.48%
(FY 2023)
About Uber Research & Health
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹1.40 Cr.
Mintu Das and Raju Saikia serve as directors at the Company.
- CIN/LLPIN
U85100AS2014PTC011813
- Company No.
011813
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Mar 2014
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Shillong
Industry
Company Details
- Location
Barpeta, Assam, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Uber Research & Health?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mintu Das  | Director | 05-Mar-2014 | Current |
| Raju Saikia | Director | 12-Oct-2020 | Current |
Financial Performance of Uber Research & Health.
Uber Research & Health Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 2.15% decrease. The company also saw a slight improvement in profitability, with a 3.98% increase in profit. The company's net worth Soared by an impressive increase of 22.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Uber Research & Health?
Unlock access to Uber Research & Health's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 15 Nov 2023 | ₹0.23 M | Open |
Others Creation Date: 30 Aug 2023 | ₹1.44 M | Open |
North Eastern Development Finance Corporation Limited Creation Date: 17 Oct 2022 | ₹1.00 M | Open |
How Many Employees Work at Uber Research & Health?
Unlock and access historical data on people associated with Uber Research & Health, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Uber Research & Health, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Uber Research & Health's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
